Hartmann's expansion programme boosts growth
This article was originally published in Clinica
The German Hartmann Group, which manufactures and markets surgical and hygiene products saw its sales rise by 10% to E1.27bn ($1.38bn) in 2002. Net income also rose by more than 50% compared with 2001, to E23.1m. This is partly due to the consolidation of the acquisition of an 80% stake in Kneipp medical company in 2001 that cost some E3m. "Our foreign expansion is paying dividends," said CEO Ulrich Hemel. He added that in addition to the 34 countries in which it is represented to date, the company would continue to look for opportunities in OECD countries and those with large populations.
You may also be interested in...
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.
Japanese ICT giant applies novel advanced computing techniques with a US venture partner to more rapidly identify lead molecules from a huge virtual space.
Keeping Track: Oncology Submissions From Blueprint, Y-mAbs, BMS/bluebird; Approvals For BMS’ Reblozyl, LFB’s SevenFact
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.